Hepatic steatosis, Visceral fat and metabolic alterations in apparently healthy overweight/obese individuals;Esteatosis hepática, Grasa visceral y alteraciones metabólicas, En individuos con sobrepeso/obesidad aparentemente sanos

Investigacion Clinica (Venezuela)

Volumn 55, Issue 1, 2014, Pages 3-14

  Ryder, Elena ^a   Mijac, Volga ^b   Fernández, Érika ^a   Palazzi, Nora ^b   Morales, María Carolina ^c   Connell, Lissette ^a   Parra, Agner ^a   Romero, Marlon ^a   Fernández, Nelson ^a  

^a Instituto de Investigaciones Clínicas Dr Américo Negrette   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

^c Clínica Falcón   (Venezuela)

Author keywords

Hepatic steatosis; Insulin resistance; Obesity; Ultrasound; Venezuela; Visceral fat

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY LIVER; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; METABOLIC DISORDER; OBESITY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VENEZUELA; WAIST CIRCUMFERENCE; ADULT; ASYMPTOMATIC DISEASE; BLOOD; BODY WEIGHT; COMORBIDITY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ASYMPTOMATIC DISEASES; BLOOD GLUCOSE; BODY MASS INDEX; COMORBIDITY; FATTY LIVER; FEMALE; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THINNESS; TRIGLYCERIDES; VENEZUELA; WAIST CIRCUMFERENCE;

EID: 84900815353     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dixon JB, Lambert GW. The obesity paradox-A reality that requires explanation and clinical interpretation. Atheroesclerosis 2013; 226: 47-48.
2. McAuley PA, Blair SN. Obesity paradoxes. J Sport Sci 2011; 29: 773-782.
3. Chrysant SG, Chrysant GS. New Insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013; 7: 85-94.
4. Bluher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19: 341-346.
5. Samaropoulus XF, Hairston KG, Anderson A, Haffner SM, Lorenzo C, Montez M, Norris JM, Scherzinger AL, Chen YD, Wagenknecht LE. A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. Obesity (Silver Spring) 2013; Feb 18. doi: 10.1002/oby.20326. Epub ahead of print.
6. Bermúdez V, Pacheco M, Rojas J, Córdova E, Velazquez R, Carrillo D, Parra MG, Toledo A, Añez R. Fonseca E, Paris Marcano R, Cano C, López Miranda J. Epidemiologic behavior of obesity in the Maracaibo City metabolic syndrome prevalence study. PLos ONE 2012; 7(4):e35392.
7. Florez H, Silva E, Fernández V, Ryder E, Sulbaran T, Campos G, Calmon G, Clavel E, Castillo-Florez S, Goldberg R. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed hispanics in Zulia state, Venezuela. Diab Res Clin Prac 2005; 69: 63-77.
8. Armellini F, Zamboni M, Rigo L, Todesco T, Bergamo-Andreis IA, Procacci C, Bosello O. The contribution of sonography to the measurement of intrabdominal fat. J Clin Ultrasound 1990; 18:563-567.
9. Csendes GP, Paolinelli GP, Busel MD, Venturelli AV, Rodríguez J. Hígado graso: ultrasonido y correlación anatomopatológica. Rev Chil Radiol 2004; 10 (2): 50-52.
10. Mathews D, Hosker J, Rudenski A, Neylor B, Tracher D, Turner R. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
11. Aschner P, Buendía R, Brajkovich I, González A, Figueredo R, Juárez XE, Uriza G, Gómez AM, Ponte CI. Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women. Diabetes Res Clin Pract 2011; 93:243-247.
12. Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2496.
13. Fernandez V, Clavell E, Villasmil JJ, Calmon G, Raleigh X, Morales LM, Campos G, Ryder E, Silva E. Niveles basales de insulina en una población del estado Zulia, Venezuela. Invest Clin 2006; 47: 167-177.
14. Buccini G, Wolftbal DL. Valores de corte para índices de insulinoresistencia, insulinosensibilidad e insulino secreción derivados de la formula HOMA y del programa HOMA2. Interpretación de los datos. Rev Argent Endocrinol Metab 2008; 45(1): 3-21.
15. Garmendia ML, Lera L, Sanchez H. Uauy R, Albala C. Valores normativos de resistencia a la insulina mediante HOMA-IR en adultos mayores de Santiago de Chile. Rev Med Chile2009; 137: 1409-1416.
16. Navarro E, Mijac V, Florez H, Ryder E. Medición ultrasonográfica de grasa visceral intrabdominal en hombres obesos. Asocia-ción con alteración de lípidos sericos e insulinemia. Arch Latinoam Nutr 2010; 60(2): 130-167.
17. Consenso Venezolano de Lípidos. International Lipid Information Bureau. Capíitulo Venezuela. Parke Davis, 2000. pp 1-39.
18. Campos G, Ryder E, Diez-Ewald M, Rivero F, Fernandez V, Raleigh X, Arocha-Piñango CL y grupo FRICVE. Prevalencia de obesidad e hiperinsulinemia en una población aparentemente sana de Maracaibo, Venezuela y su relación con las concentraciones de lípidos y lipoproteínas del suero. Invest Clin 2003; 44: 5-19.
19. Abe N, Honda S, Jahng D. Evaluation of waist circumference cut-off values as a marker for fatty liver among Japanese workers. Saf Health Work 2012; 3: 287-293.
20. Hoenig MR, Cowin G, Buckley R, McHenery C, Coulthard A. Liver fat percent is associated with metabolic risk factors and the metabolic syndrome in high-risk vascular cohorte. Nutr Metab (Lond) 2010; 7:50 doi:10.1186/1743-7075-7-50.
21. Sinn DH, Gwak GY, Park HN, Kim JE, Min YW, Kim KM, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenerol 2012; 107:561-567.
22. Karnikowski M, Cordova C, de Oliveira RJ, de Oliveira-Karnikowski MG, de Toledo-Nobrega O. Non alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J 2007; 125: 333-337.
23. Soresi M, Noto D, Cefalu AB, Martini S, Vigna GB, Fonda M, Manzato E, Cattin L, Fellin R, Averna MR, Notarbartolo A. Non-alcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arterioesclerosis society. Acta Diabetol 2013; 50 (2): 241-249.
24. Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nipels G, Dekker JM. Hepatic fat is not associated with beta cell function or postprandial free fatty acid response. Metabolism 2009; 58: 196-203.
25. Goldberg IJ, Ginsberg HN. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 2006; 130: 1343-1346.
26. Taskinen MR, Adiels M, Westeracka J, Soderlund S, Kahri J, Lundbom N, Lundbom J, Hakkarainen A, Olofsson SO, Orho-Melander M, Borén J. Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects. Arterioscler Thromb Vasc Biol 2011; 31: 2144-2150.
27. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984; 3: 9-14.
28. Younossi ZM, Stepanova M, Negro F, Hallji S, Younossi Y, Lam B, Srishord M. Non alcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012; 91:319-327.
29. Lazo M, Hemaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM. Prevalence of nonalcoholic fatty liver disease in the United States. The Third National Health and Nutrition Examination Survey, 1988-1984. Am J Epidemiol 2013; 178: 38-45.
30. Ribeiro-Filho FF, Faria AN, Azien S, Zanella MT, Ferreira SR. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res 2003; 11:1488-1494.
31. Kim SK, Kim HJ, Hur KY, Choi SH, Ahn ChW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nut 2004; 79:593-599.
32. De Lucia Rolfe E, Sleigh A, Finucane FM, Brage S, Stolk RP, Cooper C, Sharp SJ, Wareham NJ, Ong KK. Ultrasound measurements of visceral and subcutaneous abdominal thickness to predict abdominal adiposity among older men and women. Obesity (Silver Spring) 2010; 18:625-631.
33. Berker D, Koparal S, Isik S, Pasaoglu L, Aydin Y, Erol K, Delibasi T, Guler S. Compatibility of different methods for the measurement of visceral fat in different body mass index strata. Diagn Interv Radiol 2010; 16:99-105.
34. Palaniappan L. Carnethon MR, Wang Y, Hanley AJG, Fortmann SP, Haffner SM, Wagenknecht L. Predictors of the incident metabolic syndrome in adults. The Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 788-793.
35. Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients 2013; 5: 2019-2027.
36. Frayn KN. Visceral fat and insulin resistance-causative or correlative? Br J Nutr 2000; 83 (Suppl 1): S71-77.
37. Wagenknecht L., Langefeld CD, Scherzinger AL, Norris JM, Haffner SM, Saad ME, Bergman RN. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atheroesclerosis Study (IRAS) Family Study. Diabetes 2003; 52: 2490-2496.
38. Campos G, Fernández V, Fernández E, Molero E, Morales LM, Raleigh X, Connell L, Ryder E. Association of free fatty acids with the insulin-resistant state but not with central obesity in individuals from Venezuela. Invest Clin 2010; 51: 115-126.
39. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009; 106:15430-15435.
40. Bergman RN, Kim SP, Catalano KJ, Hsu Ir, Chiu JD, Kabir M, Hucking K, Ader M. Why visceral fat is bad: mechanism of the metabolic syndrome. Obesity (Silver Spring) 2006; 14 (Sup 1): 16S-19S.
41. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444(7121): 881-887.
42. Wicklow BA, Wittmeier KDM, MacIntosh AC, Sellers EAC, Ryner L, Serrai H, Dean HJ, McGavock M. Metabolic consequences of hepatic steatosis in overweight and obese adolescents. Diabetes Care 2012; 35: 905-910.
43. Lee J, Chung DS, Kang JH, Yu BY. Comparison of visceral fat and liver fat as risk factors of metabolic syndrome. J Korean Med Sci 2012; 27:184-189.